Board approved audited standalone and consolidated financial results for Q4 and year ended March 31, 2026, with unmodified audit opinion from B S R & Co. LLP.
Approved divestment of entire equity in BACC Health Care to Inviga Healthcare Fund for ₹37.64 crore, classified as related party transaction.
Re-appointed Rajiv Maliwal as Independent Director and appointed Sanjeev Kumar as CFO, both effective May 25, 2026.
Completed rights issue of 82.95 lakh shares at ₹512 per share raising ₹424.85 crore, increasing paid-up capital by ₹8.29 crore.